#hormonaldisorder
As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to #CorceptTherapeutics with a decision not to approve #relacorilant, a drug for a rare #hormonaldisorder that causes #highbloodpressure.
FDA declines to approve Corcept's rare disorder drug
As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to Corcept by turning down its new Cushing's drug.
buff.ly
January 2, 2026 at 12:30 PM
July 10, 2025 at 12:23 AM